Annual secretarial compliance report for the F.Y 31ST MARCH 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Johnson Pharmacare Ltd has filed its Annual Secretarial Compliance Report for FY 2025-26, conducted by Practicing Company Secretaries M/s Bhupendra Kaushik & Associates. The report identifies several compliance failures: the company failed to maintain the Specified Denomination Derivative (SDD) as required under SEBI Insider Trading Regulations, did not update its website per Regulation 46 of SEBI LODR, and failed to submit Related Party Transaction disclosures to the stock exchange per Regulation 23(9). Additionally, the company has not adopted or updated policies under SEBI regulations, and its statutory auditors resigned during the review period. The company also lacks both an internal auditor (mandatory under Section 138 of Companies Act) and a Chief Financial Officer (mandatory under Section 203).
Multiple compliance failures and governance gaps indicate weak internal controls. Investors should be cautious as this reflects poor regulatory adherence and potential red flags for corporate governance standards.